Skip to main content

CollPlant Biotechnologies Ltd

CLGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001631487

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding CollPlant Biotechnologies Ltd changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CLGN: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders2021+1
Shares1.74M1.57M−166.3K (−9.6%)
Value$14.3M$10.7M−$3.61M (−25.2%)

New holders (4)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CLGN in Q3 2022
InstitutionSharesValue% of portfolio
Jane Street Group, LLC13,265$90.0K0.00%
Bank of America Corp4,800$33.0K0.00%
Simplex Trading, LLC585$3.00K0.00%
National Bank of Canada250$2.00K0.00%

Sold out (3)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of CLGN in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
ARK Investment Management LLCSuperinvestorARK Invest235,660$2.19M
Tower Research Capital LLC (TRC)892$7.00K
Venture Visionary Partners LLC115$920